The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
Open accessAbstract
Cellular senescence irreversibly arrests proliferation in response to potentially oncogenic stress. Senescent cells also secrete inflammatory cytokines such as IL-6, which promote age-associated inflammation and pathology. HMGB1 (high mobility group box 1) modulates gene expression in the nucleus, but certain immune cells secrete HMGB1 as an extracellular Alarmin to signal tissue damage. We show that nuclear HMGB1 relocalized to the extracellular milieu in senescent human and mouse cells in culture and in vivo. In contrast to cytokine secretion, HMGB1 redistribution required the p53 tumor suppressor, but not its activator ATM. Moreover, altered HMGB1 expression induced a p53-dependent senescent growth arrest. Senescent fibroblasts secreted oxidized HMGB1, which stimulated cytokine secretion through TLR-4 signaling. HMGB1 depletion, HMGB1 blocking antibody, or TLR-4 inhibition attenuated senescence-associated IL-6 secretion, and exogenous HMGB1 stimulated NF-κB activity and restored IL-6 secretion to HMGB1-depleted cells. Our findings identify senescence as a novel biological setting in which HMGB1 functions and link HMGB1 redistribution to p53 activity and senescence-associated inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HMGB1 functions mainly as one of the damage-associated molecular patterns, also known as alarmins109, that are released extracellularly to induce SASP-mediated paracrine senescence and alert the immune system110.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [110]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“high-mobility-group box 1 (HMGB1)—an extracellular alarmin whose nuclear expression precedes the secretion of SASP components in cells undergoing senescence21,22.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The true extent of the SASP is now better understood; it is also comprised of hundreds of protein and non-protein signaling molecules, including proteases, hemostatic factors, ceramides, bradykinins, extracellular matrix (ECM) components, and damage-associated molecular patterns (DAMPs) (Davalos et al. 2013; Wiley et al. 2019; Basisty et al. 2020).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Davalos et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Classic SASP factors contain pro-inflammatory and immune-modulatory cytokines, chemokines, proteases, and growth factors (Table 1).190–193”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [193]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, they secreted HMGB1, a pro-inflammatory alarmin that is a feature of senescent cells (Davalos et al., 2013).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Davalos et al., 2013
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407 · cited 1×
“The redox status of reactive HMGB1 cysteines distinguishes its cytokine-inducing and chemokine activity (Venereau et al., 2012; Yang et al., 2012).”
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 3×
“Cells were considered PRE if >70% incorporated BrdU over a 2-d interval and <10% expressed SA--Gal. Cells were considered SEN after 7–10 d; <10% incorporated BrdU and >80% expressed SA--Gal (Dimri et al., 1995).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · cited 1×
“The senescence arrest was long considered a cell-intrinsic process (Hayflick, 1965).”
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 4×
“…stimulates inflammatory cytokine secretion by immune cells (Andersson et al., 2002; Dumitriu et al., 2005; Yamada and Maruyama, 2007), and such cytokines are SASP components (Coppé et al., 2008, 2010b), we asked whether senescence caused by altered HMGB1 expression increased cytokine secretion.”
InfluentialSelf-citationCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“…suppressor pathways governed by p53 and pRB, transcriptional regulators that establish and maintain the senescence arrest (Herbig et al., 2006; Campisi and d'Adda di Fagagna, 2007). p53 arrests the cells primarily by inducing the p21 gene, which inhibits cyclin-dependent kinases and cell…”
Self-citationRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 1×
“Because HMGB1 binds DNA loosely and transiently (Scaffidi et al., 2002), early chromatin remodeling during senescence may release HMGB1.”
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 6×
“Intracellular and extracellular HMGB1 regulate the SASP Stressed cells secrete DAMPs, including HMGB1 (Bianchi, 2007; Lotze et al., 2007), which also function intracellularly.”
InfluentialHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487 · cited 1×
“Extracellular HMGB1 binds cell surface RAGE (receptor for advanced glycation end-products) and TLRs (toll-like receptors) to initiate signaling that culminates in the expression of inflammatory cytokines such as interleukin (IL)-6 (Park et al., 2003, 2006; Lotze and Tracey, 2005; Schiraldi et al., 2012).”
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“HMGB1 secretion may also initiate the removal of senescent cells by innate immune cells, which has been described in mouse models of tumorigenesis and liver fibrosis (Xue et al., 2007; Krizhanovsky et al., 2008).”
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 18×
“After 10 d, cells were scored for SAHFs.”
InfluentialPersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“However, recent findings identified secreted proteins that partly reinforce the arrest in an autocrine manner (Kortlever et al., 2006; Acosta et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008).”
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“This finding reinforces the idea that senescence entails a series of defined events (Rodier and Campisi, 2011), similar to apoptosis (Green, 2005).”
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 1×
“HMGB1 secretion may also initiate the removal of senescent cells by innate immune cells, which has been described in mouse models of tumorigenesis and liver fibrosis (Xue et al., 2007; Krizhanovsky et al., 2008).”
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 1×
“However, recent findings identified secreted proteins that partly reinforce the arrest in an autocrine manner (Kortlever et al., 2006; Acosta et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008).”
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 5×
“To inactivate p53, we used the genetic suppressor element (GSE) 22 (Gudkov et al., 1993; Beauséjour et al., 2003).”
InfluentialSelf-citationHMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437 · cited 2×
“Extracellular HMGB1 is thought to contribute to age-related pathologies such as cardiovascular disease and cancer by stimulating chronic inflammation, a characteristic of aging tissues (Kohno et al., 2009; Tang et al., 2010; Andersson and Tracey, 2011).”
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372 · cited 1×
“Recent findings suggest HMGB1 complexes with extracellular molecules such as single-stranded DNA or IL-1 to promote inflammation (Ivanov et al., 2007; Tian et al., 2007; Sha et al., 2008).”
Inflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354 · cited 2×
“For example, after 6 d in TSA, which alters chromatin, its secretion initiates the SASP and, hence, the inflammatory activity of senescent cells (Coppé et al., 2010a; Freund et al., 2010).”
Self-citationMonocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249 · cited 4×
“Further, although HMGB1 depletion and overexpression both induced growth arrest, SA--Gal, and SAHF, only overexpression caused HMGB1 secretion, NF-B cells lost nuclear HMGB1, as reported for monocytes (Bonaldi et al., 2003), and ceased growth, but <15% of cells expressed SA--Gal and adopted a senescent morphology.”
InfluentialOxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116 · cited 2×
“MEFs were isolated from C57BL/6 13.5-d embryos, and cultured in 3% O 2 (Parrinello et al., 2003).”
InfluentialSelf-citationCellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 5×
“…(Beauséjour et al., 2003; Narita et al., 2003); TLR-4, 5-ATATTAAGG- TAGAGAGGTGGC-3 (OpenBiosystems, TRCN0000056894); RELA, 5-AACTCATCATAGTTGATGGTG-3 (OpenBiosystems, TRCN0000014686; Freund et al., 2011); and ATM, 5-TGAAGATGGTGCTCATAAA-3 (Open Biosystems, TRCN0000039948; Rodier et al., 2009).”
InfluentialSelf-citationA Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau, E., Ruhl, V. E., Rodier, F., Smith, C. L., Rahmberg, B. L., Fuss, J. O., Campisi, J., Yaswen, P., Cooper, P. K., & Kaufman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006529 · Cited by 964 · cited 1×
“We also used a sequence verified HMGB1 cDNA (TC118802; Origene) cloned into a modified lentiviral vector (670–1) that conferred puromycin resistance (Campeau et al., 2009).”
Self-citationHigh mobility group box 1 protein interacts with multiple Toll-like receptors
Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.-Y., Strassheim, D., Sohn, J.-W., Yamada, S., Maruyama, I., Banerjee, A., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2005 · Cited by 932 · cited 1×
“…HMGB1 binds cell surface RAGE (receptor for advanced glycation end-products) and TLRs (toll-like receptors) to initiate signaling that culminates in the expression of inflammatory cytokines such as interleukin (IL)-6 (Park et al., 2003, 2006; Lotze and Tracey, 2005; Schiraldi et al., 2012).”
Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926 · cited 3×
“HMGB1 passively leaks from necrotic, but not apoptotic, cells, is actively secreted by pathogen-stimulated macrophages, and mediates the potentially lethal inflammation caused by endotoxins (Gardella et al., 2002).”
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 1×
“However, recent findings identified secreted proteins that partly reinforce the arrest in an autocrine manner (Kortlever et al., 2006; Acosta et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008).”
Apoptotic Pathways: Ten Minutes to Dead
Green, D. R. (2005) · Cell · doi:10.1016/j.cell.2005.05.019 · Cited by 827 · cited 1×
“This finding reinforces the idea that senescence entails a series of defined events (Rodier and Campisi, 2011), similar to apoptosis (Green, 2005).”
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Grosschedl, R., Giese, K., & Pagel, J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90232-1 · Cited by 813 · cited 1×
“HMGB1 is an abundant, evolutionarily conserved nonhistone protein (Goodwin et al., 1973) that bends DNA to provide transcription factor access to promoter regions (Grosschedl et al., 1994).”
A New Group of Chromatin‐Associated Proteins with a High Content of Acidic and Basic Amino Acids
Goodwin, G. H., Sanders, C., & Johns, E. W. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb03026.x · Cited by 780 · cited 1×
“HMGB1 is an abundant, evolutionarily conserved nonhistone protein (Goodwin et al., 1973) that bends DNA to provide transcription factor access to promoter regions (Grosschedl et al., 1994).”
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762 · cited 2×
“HMGB1 released by immune cells signals primarily through the RAGE and TLR4 receptors (Klune et al., 2008; Tang et al., 2010).”
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720 · cited 3×
“The redox state of HMGB1 determines whether it stimulates inflammatory cytokine secretion or acts as a chemoattractant to recruit immune cells (Venereau et al., 2012).”
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696 · cited 1×
“Because SEN cells increase with age in mammalian tissues (Dimri et al., 1995; Herbig et al., 2006; Wang et al., 2009), we examined kidneys from young (4 mo) and old (32 mo) mice for nuclear HMGB1 (Fig.”
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676 · cited 2×
“…HMGB1 binds cell surface RAGE (receptor for advanced glycation end-products) and TLRs (toll-like receptors) to initiate signaling that culminates in the expression of inflammatory cytokines such as interleukin (IL)-6 (Park et al., 2003, 2006; Lotze and Tracey, 2005; Schiraldi et al., 2012).”
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654 · cited 1×
“After 24 h, TNF and IL-1 stimulated IL-6 secretion, regardless of HMGB1 status, as expected (Ammit et al., 2000; Orjalo et al., 2009). rHMGB1 failed to stimulate IL-6 secretion in PRE cells, despite inducing nuclear localization of NF-B (Fig.”
Self-citationLotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641 · cited 2×
“Stressed cells secrete DAMPs, including HMGB1 (Bianchi, 2007; Lotze et al., 2007), which also function intracellularly.”
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 1×
“However, recent findings identified secreted proteins that partly reinforce the arrest in an autocrine manner (Kortlever et al., 2006; Acosta et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008).”
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · cited 1×
“These proteins comprise a larger senescence-associated secretory phenotype (SASP), featuring growth factors, proteases, and inflammatory cytokines that affect neighboring cells in a paracrine manner (Parrinello et al., 2005; Bavik et al., 2006; Coppé et al., 2008, 2010b).”
Self-citationA novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629 · cited 3×
“In this regard, HMGB1 differs from high mobility group A (HMGA) proteins, which accumulate on chromatin in SEN cells (Narita et al., 2006).”
InfluentialRodier, F., Muñoz, D. P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., Coppé, J.-P., Campeau, E., Beauséjour, C. M., Kim, S.-H., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.071340 · Cited by 535 · cited 3×
“However, DNA damage response (DDR) proteins that act upstream of p53 (ATM, NBS1, CHK2, H2AX) are required for the SASP (Rodier et al., 2009, 2011).”
Self-citationHigh-mobility group box 1 and cancer
Tang, D., Kang, R., Zeh III, H. J., & Lotze, M. T. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.014 · Cited by 512
Coppé, J.-P., Rodier, F., Patil, C. K., Freund, A., Desprez, P.-Y., & Campisi, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257071 · Cited by 506 · cited 3×
“S4 E), which does not cause a SASP (Coppé et al., 2011), suggesting that HMGB1 relocalization and the SASP are regulated differently.”
Self-citationBhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Orjalo, A. V., Rodier, F., Lithgow, G. J., & Campisi, J. (2009) · Aging · doi:10.18632/aging.100042 · Cited by 500 · cited 2×
“Although the SASP does not require p53 activity, it requires DDR signaling (Coppé et al., 2008; Bhaumik et al., 2009; Rodier et al., 2009, 2011; Le et al., 2010), and cells lacking ATM, a key DDR component, senesce with much reduced cytokine secretion (Rodier et al., 2009).”
Self-citationA novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S., Dragoi, A.-M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 470 · cited 1×
“Recent findings suggest HMGB1 complexes with extracellular molecules such as single-stranded DNA or IL-1 to promote inflammation (Ivanov et al., 2007; Tian et al., 2007; Sha et al., 2008).”
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455 · cited 4×
“…stimulates inflammatory cytokine secretion by immune cells (Andersson et al., 2002; Dumitriu et al., 2005; Yamada and Maruyama, 2007), and such cytokines are SASP components (Coppé et al., 2008, 2010b), we asked whether senescence caused by altered HMGB1 expression increased cytokine secretion.”
InfluentialSelf-citationBavik, C., Coleman, I., Dean, J. P., Knudsen, B., Plymate, S., & Nelson, P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1716 · Cited by 453 · cited 1×
“These proteins comprise a larger senescence-associated secretory phenotype (SASP), featuring growth factors, proteases, and inflammatory cytokines that affect neighboring cells in a paracrine manner (Parrinello et al., 2005; Bavik et al., 2006; Coppé et al., 2008, 2010b).”
Activation of gene expression in human neutrophils by high mobility group box 1 protein
Park, J. S., Arcaroli, J., Yum, H.-K., Yang, H., Wang, H., Yang, K.-Y., Choe, K.-H., Strassheim, D., Pitts, T. M., Tracey, K. J., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2002 · Cited by 433
Bianchi, M. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008585 · Cited by 416 · cited 1×
“Extracellular DAMPs induce a sterile inflammatory response (Bianchi, 2007, 2009; Andersson and Tracey, 2011).”
HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
Sha, Y., Zmijewski, J., Xu, Z., & Abraham, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2531 · Cited by 393 · cited 1×
“Recent findings suggest HMGB1 complexes with extracellular molecules such as single-stranded DNA or IL-1 to promote inflammation (Ivanov et al., 2007; Tian et al., 2007; Sha et al., 2008).”
Cellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390 · cited 2×
“Cellular senescence suppresses cancer by arresting the proliferation of cells at risk for malignant transformation (Campisi, 2001; Prieur and Peeper, 2008).”
Self-citationMüller, S., Ronfani, L., & Bianchi, M. E. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01296.x · Cited by 367 · cited 2×
“As reported (Müller et al., 2004), unirradiated brain stained weakly for HMGB1, but the staining was mostly nuclear; after XRA, nuclear staining diminished (Fig.”
Masquerader: High Mobility Group Box-1 and Cancer
Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., & Lotze, M. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1953 · Cited by 355 · cited 5×
“Extracellular HMGB1 is thought to contribute to age-related pathologies such as cardiovascular disease and cancer by stimulating chronic inflammation, a characteristic of aging tissues (Kohno et al., 2009; Tang et al., 2010; Andersson and Tracey, 2011).”
InfluentialInflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured?
Franceschi, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00358.x · Cited by 342 · cited 1×
“Immunostaining showed abundant 2002; Franceschi, 2007), the SASP can, in principle, account for the antagonistic pleiotropy.”
HMGB1: guiding immunity from within
Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E., & Rovere-Querini, P. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.009 · Cited by 340 · cited 2×
“Because extracellular HMGB1 stimulates inflammatory cytokine secretion by immune cells (Andersson et al., 2002; Dumitriu et al., 2005; Yamada and Maruyama, 2007), and such cytokines are SASP components (Coppé et al., 2008, 2010b), we asked whether senescence caused by altered HMGB1 expression…”
Semino, C., Angelini, G., Poggi, A., & Rubartelli, A. (2005) · Blood · doi:10.1182/blood-2004-10-3906 · Cited by 328 · cited 1×
“Necrotic cells passively leak HMBG1, but immune cells actively secrete this protein to amplify inflammatory stimuli such as those initiated by lipopolysaccharide, interferons, or nitric oxide (Wang et al., 1999a,b; Semino et al., 2005).”
High mobility group protein-1 (HMG-1) is a unique activator of p53
Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 321 · cited 1×
“One such factor is p53 for which HMGB1 increases DNA binding and transactivation activity (Jayaraman et al., 1998; Banerjee and Kundu, 2003).”
TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain
Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y., & Kimura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.026 · Cited by 313 · cited 1×
“However, lentiviral-delivered shRNA against TLR-4, which reduced TLR4 mRNA 50%, as well as CLI-95, a small molecule inhibitor of TLR-4 signaling (Kawamoto et al., 2008), both significantly reduced IL-6 secretion by SEN cells (Fig.”
Inflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured?
Franceschi, C. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s173-s176 · Cited by 308
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 7×
“Neither pRB nor p53 are required for the SASP, and p53 deficiency amplifies the SASP (Coppé et al., 2008, 2011).”
InfluentialHMGB1 as a DNA-binding cytokine
Andersson, U., Erlandsson-Harris, H., Yang, H., & Tracey, K. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1084 · Cited by 302 · cited 2×
“Because extracellular HMGB1 stimulates inflammatory cytokine secretion by immune cells (Andersson et al., 2002; Dumitriu et al., 2005; Yamada and Maruyama, 2007), and such cytokines are SASP components (Coppé et al., 2008, 2010b), we asked whether senescence caused by altered HMGB1 expression…”
Wang, H., Vishnubhakat, J. M., Bloom, O., Zhang, M., Ombrellino, M., Sama, A., & Tracey, K. J. (1999) · Surgery · doi:10.1016/s0039-6060(99)70182-0 · Cited by 292 · cited 2×
“HMGBI has a surprising additional function—as a secreted protein (Wang et al., 1999a) with a central role in inflammation caused by cell or tissue damage (Bianchi, 2007; Yamada and Maruyama, 2007).”
Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., & Bartek, J. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14707 · Cited by 283 · cited 1×
“First, although IMR-90 cells senesce with SAHF (Narita et al., 2003), these structures are not a universal feature of SEN cells (Kosar et al., 2011).”
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260 · cited 1×
“Cellular senescence suppresses cancer by arresting the proliferation of cells at risk for malignant transformation (Campisi, 2001; Prieur and Peeper, 2008).”
Palumbo, R., Galvez, B. G., Pusterla, T., De Marchis, F., Cossu, G., Marcu, K. B., & Bianchi, M. E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704015 · Cited by 250 · cited 1×
“9 F), as demonstrated for mouse cells (Palumbo et al., 2007).”
Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes
Campisi, J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00152-3 · Cited by 218 · cited 4×
“Western analyses were performed as described previously , loading either 30 µg protein or concentrated medium equivalent to 3–6 × 10 5 cells per lane (Davalos and Campisi, 2003).”
InfluentialSelf-citationAmmit, A. J., Lazaar, A. L., Irani, C., O'Neill, G. M., Gordon, N. D., Amrani, Y., Penn, R. B., & Panettieri, R. A. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.4.4681 · Cited by 201
HMGB1: A signal of necrosis: Review
Raucci, A., Palumbo, R., & Bianchi, M. E. (2007) · Autoimmunity · doi:10.1080/08916930701356978 · Cited by 195 · cited 6×
“5 mM) that caused necrosis also caused HMGB1 release, as expected (Raucci et al., 2007), which was unaffected by LMB (Fig.”
InfluentialBrezniceanu, M.-L., Völp, K., Bösser, S., Solbach, C., Lichter, P., Joos, S., & Zörnig, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0621fje · Cited by 192 · cited 3×
“Many tumor cell lines and tumors express high levels of HMGB1 (Brezniceanu et al., 2003; Ellerman et al., 2007), suggesting HMGB1 might be an oncogene that allows bypass of senescence signals.”
InfluentialKohno, T., Anzai, T., Naito, K., Miyasho, T., Okamoto, M., Yokota, H., Yamada, S., Maekawa, Y., Takahashi, T., Yoshikawa, T., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn291 · Cited by 175
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.
Ossovskaya, V. S., Mazo, I. A., Chernov, M. V., Chernova, O. B., Strezoska, Z., Kondratov, R., Stark, G. R., Chumakov, P. M., & Gudkov, A. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10309 · Cited by 171 · cited 2×
“To determine the role of p53, we expressed a dominant-negative p53 peptide (GSE22; Ossovskaya et al., 1996) or depleted p53 by RNAi.”
Le, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168 · cited 4×
“Although the SASP does not require p53 activity, it requires DDR signaling (Coppé et al., 2008; Bhaumik et al., 2009; Rodier et al., 2009, 2011; Le et al., 2010), and cells lacking ATM, a key DDR component, senesce with much reduced cytokine secretion (Rodier et al., 2009).”
InfluentialSelf-citationLiu, S., Stolz, D. B., Sappington, P. L., Macias, C. A., Killeen, M. E., Tenhunen, J. J., Delude, R. L., & Fink, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00308.2005 · Cited by 159 · cited 1×
“In contrast to certain other cells in which secreted HMGB1 is in exosomes or insoluble fractions (Liu et al., 2006), HMGB1 secreted by SEN cells was predominantly soluble (Fig.”
Stress-induced Premature Senescence (SIPS)
Suzuki, M., & Boothman, D. A. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07081 · Cited by 152 · cited 1×
“Depletion of p53 produced retention of HMGB1 after senescence induced by Senescence is a stress response, although not all stressors induce senescence (Suzuki and Boothman, 2008).”
Kim, J., & Wong, P. K. Y. (2009) · Stem Cells · doi:10.1002/stem.125 · Cited by 147 · cited 1×
“ATM-deficient cells also show chromatin alterations, as well as levels of reactive oxygen species (ROS; Kim and Wong, 2009) that can provoke loss of nuclear HMGB1 (Tang et al.”
HMGB1, a novel inflammatory cytokine
Yamada, S., & Maruyama, I. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.019 · Cited by 146 · cited 2×
“, 1999a) with a central role in inflammation caused by cell or tissue damage (Bianchi, 2007; Yamada and Maruyama, 2007).”
Gudkov, A. V., Zelnick, C. R., Kazarov, A. R., Thimmapaya, R., Suttle, D. P., Beck, W. T., & Roninson, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3231 · Cited by 136 · cited 1×
“To inactivate p53, we used the genetic suppressor element (GSE) 22 (Gudkov et al., 1993; Beauséjour et al., 2003).”
High Mobility Group 1 Protein Is Not Stably Associated with the Chromosomes of Somatic Cells
Falciola, L., Spada, F., Calogero, S., Längst, G., Voit, R., Grummt, I., & Bianchi, M. E. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.19 · Cited by 124 · cited 1×
“HMGB1 preferentially binds euchromatin (Falciola et al., 1997).”
Ammit, A. J., Hoffman, R. K., Amrani, Y., Lazaar, A. L., Hay, D. W. P., Torphy, T. J., Penn, R. B., & Panettieri, R. A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.6.4184 · Cited by 118 · cited 1×
“After 24 h, TNF and IL-1 stimulated IL-6 secretion, regardless of HMGB1 status, as expected (Ammit et al., 2000; Orjalo et al., 2009). rHMGB1 failed to stimulate IL-6 secretion in PRE cells, despite inducing nuclear localization of NF-B (Fig.”
Davalos, A. R., & Campisi, J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304016 · Cited by 115 · cited 3×
“Western analyses were performed as described previously , loading either 30 µg protein or concentrated medium equivalent to 3–6 × 10 5 cells per lane (Davalos and Campisi, 2003).”
Self-citationSmart, P., Lane, E. B., Lane, D. P., Midgley, C., Vojtesek, B., & Laín, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203260 · Cited by 81 · cited 1×
“High (2 µM) LMB doses and long exposures increase nuclear p53 and induce senescence (Smart et al., 1999).”
The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription
Banerjee, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg412 · Cited by 58 · cited 1×
“One such factor is p53 for which HMGB1 increases DNA binding and transactivation activity (Jayaraman et al., 1998; Banerjee and Kundu, 2003).”
Coffee Consumption and Risk of Type 2 Diabetes and Heart Disease
Campos, H., & Baylín, A. (2007) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00297.x · Cited by 40
Nair, A. R., Schliekelman, M. J., Thomas, M. B., Wakefield, J., Jurgensen, S. R., & Ramabhadran, R. (2005) · Cell Cycle · doi:10.4161/cc.4.5.1672 · Cited by 14 · cited 2×
“Expression vectors and siRNA The following sequences were used to target the indicated proteins by RNAi: HMGB-#1, 5-GAGGCCTCCTTCGGCCTTC-3; HMGB1-#2, 5-GTTGGTTCTAGCGCAGTTT-3; p53, 5-GACUCCATRGGUAAUCUAC-3 (Nair et al., 2005); p16INK4a, 5-CGCTGTGGCCCTCGTGCTGATGCTA3 (Beauséjour et al.”
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationCellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Jeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515
Self-citationInflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
Metadata
- Authors
- Davalos, A. R., Kawahara, M., Malhotra, G. K., Schaum, N., Huang, J., Ved, U., Beausejour, C. M., Coppe, J.-P., Rodier, F., & Campisi, J.
- Affiliations
- Buck Institute for Research on Aging (US)
- Lawrence Berkeley National Laboratory (US)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA 94720 1
- Corresponding author
- Davalos, Albert R.
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2013-05-06
- Volume
- 201
- Issue
- 4
- Pages
- 613-629
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3653366
- OpenAlex
- W2162229546
- Cited by
- 439
- References
- 86
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 28 · 2023: 41 · 2022: 58 · 2021: 50 · 2020: 50 · 2019: 42 · 2018: 33 · 2017: 23 · 2016: 22 · 2015: 17 · 2014: 8 · 2013: 2
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- U.S. Department of Energy (AC03-76SF00098)
- Buck Institute for Research on Aging
- National Institutes of Health (AG09909, AG017242)
- National Institute on Aging (R56AG009909, AG017242, AG-09909, R37AG009909, P01AG017242)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, HMGB1, alarmins, p53, senescence-associated inflammation, TLR4 signaling, NF-κB, extracellular HMGB1, fibroblasts, ATM, age-associated inflammation
- MeSH terms
- Animals, Cell Nucleus, DNA-Binding Proteins, Fibroblasts, Gene Expression Regulation, Humans, Inflammation, Mice, Inbred C57BL, Signal Transduction, Interleukin-6, Tumor Suppressor Protein p53, Cytokines, NF-kappa B, Cellular Senescence, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, HMGB1 Protein, Tumor Suppressor Proteins, Cell Proliferation, Toll-Like Receptor 4, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.